Understanding how different cells respond to viral infections
Harnessing cell-to-cell variability to understand viral infection outcomes
This study looks at how different cells in our body react to the Herpes Simplex Virus 1, trying to find out why some cells can stop the virus while others make a lot of it; the goal is to learn more about these responses to help create better treatments for viral infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11079320 on NIH RePORTER |
What this research studies
This research investigates how individual cells respond differently to viral infections, specifically focusing on Herpes Simplex Virus 1 (HSV-1). By examining the variability in infection outcomes at the single-cell level, the study aims to identify why some cells can abort the infection while others become 'super producers' that release large amounts of virus. The research employs advanced technologies to analyze these interactions and seeks to uncover the molecular mechanisms that dictate these diverse responses. This understanding could lead to the development of new antiviral therapies and improve treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals infected with Herpes Simplex Virus 1 (HSV-1) who are interested in understanding their infection outcomes.
Not a fit: Patients who are not infected with HSV-1 or those with other unrelated viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative antiviral treatments that enhance the body's ability to combat viral infections.
How similar studies have performed: Previous research has shown promise in understanding viral infections at the single-cell level, indicating that this approach could yield valuable insights.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Drayman, Nir — University of California-Irvine
- Study coordinator: Drayman, Nir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.